Back    Zoom +    Zoom -
JD HEALTH, CHINA RES SANJIU Deepen Cooperation in Areas Like Omni Channel Pharmaceutical Retail
Recommend
6
Positive
6
Negative
6
JD HEALTH (06618.HK) and CHINA RES SANJIU(000999.SZ), a subsidiary of CHINARES PHARMA (03320.HK), entered into a strategic cooperation agreement in Beijing, aiming to deepen cooperation in omni channel pharmaceutical retail, digital marketing and corporate social responsibility.

The collaboration marks that the two parties will comprehensively deepen cooperation in areas like omni channel pharmaceutical retail, pharmaceutical digital marketing and corporate social responsibility, so as to jointly create a new benchmark for omni channel pharmaceutical retail cooperation.

Related NewsM Stanley Ratings, TPs on CN Healthcare Related Stocks (Table)

AAStocks Financial News